To explore the potential role of YAP1 in primary resistance to cetuximab in CRC, we performed a comprehensive bioinformatic analysis using RNA microarray data [24] from CRC cell lines with known cetuximab-response status (GSE59857). The gene discussed is YAP1; the disease is colorectal carcinoma.